Webinar: Digital Health Reimbursement in France
Webinar: 12 Dec 2023, 16:00 CET
As digital health continues to revolutionize healthcare delivery, the French market holds immense potential for innovators and offers the most extensive market access opportunities for digital health in Europe. Join us at our webinar to delve into the latest changes of the French Market Access Pathways for digital health. We will talk about the new innovation pathway for digital health (PECAN) as well as regular market access routes for remote patient monitoring solutions and digital therapeutics (DTx).
For more information about each topic, click on the topic to see the corresponding blog post:
- PECAN: The new pathway to condtional reimbursement
- Transition from Etapes to TLS for remote monitoring
- LPPR registration for therapeutic digital solutions
- Introduction of organisational benefits.
Whether you are a startup or an established player in digital health, this webinar is your gateway to success in gaining access to the French market.
In this webinar you will be able to hear from the experts who successfully have supported several companies through these programs.
Ouassim NAIET EL GAIED
Ouassim, a pharmacist who graduated in 2016 and a former resident pharmacist, holds a master’s degree in international regulatory affairs from the Faculty of Pharmacy in Lille, France, as well as a university diploma in market access and health economics from the Faculty of Pharmacy in Monastir, Tunisia. Ouassim has a great interest for digital health for which he is developing an extensive experience. In fact, he is managing digital health related projects at MediTech Access since 2021. He was previously working at BioSerenity, where he managed early market access phases for connected medical devices in cardiology, neurology and sleep medicine. Before this, he was a global market access intern at Air Liquide Healthcare International, where he was actively involved in developing market access strategies for medical devices, such as a digital solution in oncology.
Michel is a renowned expert in health economics, Market Access, pricing, and reimbursement, boasting over 30 years of experience in leadership roles for industry giants like Johnson and Johnson, Baxter, Linde, Allianz/World Aid, and Edward Lifesciences. His accomplishments include securing funding and reimbursement for groundbreaking innovations such as transcutaneous aortic valves (TAVI) in multiple countries and developing expertise in various therapeutic areas. As the CEO of MediTech Access, a consulting firm he founded in 2012, Michel continues to empower Medtech companies and startups, facilitating early funding and reimbursement strategies in French-speaking countries.